This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Jjp Biologics Sp. Z O.o.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Petrus Johannes Simons: Innovator in Antibody Research
Introduction
Petrus Johannes Simons is a notable inventor based in Utrecht, Netherlands. He has made significant contributions to the field of antibody research, holding 2 patents that focus on innovative therapeutic applications.
Latest Patents
His latest patents include "Anti-Human Hvem (TNFRSF14) Antibodies And Uses Thereof" and "Anti-human CD89 antibodies and uses thereof." The latter invention discloses an antibody that binds to the extracellular part of human CD89 (human FcαRI) on human CD89 expressing cells. This binding prevents the interaction of human IgA with human CD89, leading to reduced cell death in these cells compared to the antibody MIP8a. The invention also outlines the use of such antibodies in combating specific diseases.
Career Highlights
Petrus is associated with JJP Biologics Sp. z o.o., where he continues to advance his research in antibody development. His work is pivotal in the ongoing exploration of therapeutic antibodies and their applications in medicine.
Collaborations
He collaborates with esteemed colleagues, including Louis Boon and Marcel Theodorus Den Hartog, who contribute to his research endeavors.
Conclusion
Petrus Johannes Simons is a prominent figure in the field of antibody research, with a focus on innovative solutions for medical challenges. His contributions are shaping the future of therapeutic applications in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile